SML2199
L-F001
≥98% (HPLC)
别名:
5-(3R)-1,2-Dithiolan-3-yl-1-[hexahydro-4-(5-isoquinolinylsulfonyl)-1H-1,4-diazepin-1-yl]-1-pentanone
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
oil
Storage condition:
desiccated
assay
≥98% (HPLC)
form
oil
storage condition
desiccated
color
colorless to light brown
storage temp.
2-8°C
SMILES string
O=C(CCCC[C@@H]1CCSS1)N2CCN(S(C3=CC=CC4=C3C=CN=C4)(=O)=O)CCC2
InChI
1S/C22H29N3O3S3/c26-22(8-2-1-6-19-10-16-29-30-19)24-12-4-13-25(15-14-24)31(27,28)21-7-3-5-18-17-23-11-9-20(18)21/h3,5,7,9,11,17,19H,1-2,4,6,8,10,12-16H2/t19-/m1/s1
InChI key
NWTRUKNNHUXONB-LJQANCHMSA-N
Biochem/physiol Actions
L-F001 is a multifunctional, brain penetrant and potent Rho-associated protein kinase (ROCK) inhibitor that protects the PC12 cells from paraquat induced cytotoxicity. L-F001 suppresses neuroinflammation in vitro and in vivo.
multifunctional, brain penetrant and potent Rho-associated protein kinase (ROCK) inhibitor
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Jingkao Chen et al.
European journal of pharmacology, 806, 1-9 (2017-03-23)
Microglia and astrocytes are largely responsible for inflammatory injury in the brain of Alzheimer's disease (AD). Increasing evidence has indicated that Rho kinase (ROCK) plays an important role in the regulation of neuroinflammation. Previously, we synthesized a new chemical entity
Liting Luo et al.
Neurochemical research, 42(2), 615-624 (2017-01-13)
Amounting evidences demonstrated that Rho/Rho-associated kinase (ROCK) might be a novel target for the therapy of Parkinson's disease (PD). Recently, we synthesized L-F001 and revealed it was a potent ROCK inhibitor with multifunctional effects. Here we investigated the effects of
Wei Shen et al.
Biochemical and biophysical research communications, 464(3), 794-799 (2015-07-19)
Paraquat (PQ) was demonstrated to induce dopaminergic neuron death and is used as a Parkinson's disease (PD) mimetic. Amounting evidences demonstrated that Rho/ROCK may a novel target for the therapy of PD. Previously we synthesized L-F001 and proved it is
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML2199-25MG | 04061835303687 |
| SML2199-5MG | 04061835303694 |